Top News
PenetriumBioScience Files U.S. FDA IND for Phase 2a Trial in Advanced...
Penitrium Bioscience enters Phase 2a clinical trials in the U.S. for its cancer drug candidate 'Penitrium.'
- Our Sponsors Ad -
